Pfizer and Its Chairman and CEO Dr. Albert Bourla to Receive the 2024 AACR Outstanding Achievement Award for Service to Cancer Science and Medicine

The American Association for Cancer Research (AACR) will honor Pfizer Inc., as well as Pfizer’s Chairman and Chief Executive Officer, Albert Bourla, PhD, with the 2024 AACR Outstanding Achievement Award for Service to Cancer Science and Medicine during the AACR Annual Meeting 2024, to be held April 5-10 in San Diego, California. Bourla will accept the award and give remarks during the meeting’s Opening Ceremony, which begins Sunday, April 7 at 8 a.m. PT. Pfizer, along with Bourla as its Chairman and CEO, is being honored for its long-standing and impressive work in oncology, its deep-rooted commitment to scientific innovation in the development of novel cancer therapeutics, and its steadfast and enduring commitment to the AACR.

Login Or Register To Read Full Story